To data, there have been 13 reported injuries. Becton Dickinson (BD)/Carefusion 303 is recalling the Alaris infusion pump due to incompatibility issues with Cardinal Health Monoject syringes. The Food ...
The FDA has identified this as a Class I recall, the most serious type of recall. There have been 13 reported injuries. There have been no reports of death. Get the Strategy to Trade Pre-Fed Setups ...
FRANKLIN LAKES, N.J., Sept. 21, 2020 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today provided an update on previously announced ...
This clearance covers updated hardware features for Point-of-Care Unit (PCU), large volume pumps, syringe pumps, patient-controlled analgesia (PCA) pumps, respiratory monitoring and ...
FRANKLIN LAKES, N.J., April 26, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has submitted a 510(k) premarket ...
ST. LOUIS--(BUSINESS WIRE)-- Amerinet Choice, Amerinet’s private label and sourcing company, recently named CareFusion as their “Choice Safety Partner,” for the delivery of smart infusion systems and ...
BD (Becton, Dickinson and Company), a leading global medical technology company, announced that the updated BD Alaris Infusion System has received 510(k) clearance from the US Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results